OSE Immunotherapeutics SA (EPA:OSE)

OSE Immunotherapeutics Statistics

Total Valuation

EPA:OSE has a market cap or net worth of EUR 106.54 million. The enterprise value is 114.40 million.

Market Cap	106.54M
Enterprise Value	114.40M

Important Dates

The next estimated earnings date is Thursday, March 26, 2026.

Earnings Date	Mar 26, 2026
Ex-Dividend Date	n/a

Share Statistics

EPA:OSE has 22.42 million shares outstanding. The number of shares has increased by 3.76% in one year.

Current Share Class	22.42M
Shares Outstanding	22.42M
Shares Change (YoY)	+3.76%
Shares Change (QoQ)	+3.65%
Owned by Insiders (%)	24.14%
Owned by Institutions (%)	3.12%
Float	16.21M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	59.79
PB Ratio	3.18
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.52
EV / Sales	64.20
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.23

Financial Position

The company has a current ratio of 1.54, with a Debt / Equity ratio of 1.06.

Current Ratio	1.54
Quick Ratio	1.19
Debt / Equity	1.06
Debt / EBITDA	n/a
Debt / FCF	-1.32
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -66.82% and return on invested capital (ROIC) is -66.55%.

Return on Equity (ROE)	-66.82%
Return on Assets (ROA)	-18.42%
Return on Invested Capital (ROIC)	-66.55%
Return on Capital Employed (ROCE)	-50.40%
Weighted Average Cost of Capital (WACC)	5.72%
Revenue Per Employee	27,844
Profits Per Employee	-508,109
Employee Count	64
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -27.00% in the last 52 weeks. The beta is 0.61, so EPA:OSE's price volatility has been lower than the market average.

Beta (5Y)	0.61
52-Week Price Change	-27.00%
50-Day Moving Average	5.02
200-Day Moving Average	5.68
Relative Strength Index (RSI)	40.36
Average Volume (20 Days)	74,199

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, EPA:OSE had revenue of EUR 1.78 million and -32.52 million in losses. Loss per share was -1.48.

Revenue	1.78M
Gross Profit	1.78M
Operating Income	-30.68M
Pretax Income	-32.52M
Net Income	-32.52M
EBITDA	-29.47M
EBIT	-30.68M
Loss Per Share	-1.48

Balance Sheet

The company has 27.81 million in cash and 35.66 million in debt, with a net cash position of -7.85 million or -0.35 per share.

Cash & Cash Equivalents	27.81M
Total Debt	35.66M
Net Cash	-7.85M
Net Cash Per Share	-0.35
Equity (Book Value)	33.52M
Book Value Per Share	1.52
Working Capital	12.51M

Cash Flow

In the last 12 months, operating cash flow was -26.60 million and capital expenditures -450,000, giving a free cash flow of -27.05 million.

Operating Cash Flow	-26.60M
Capital Expenditures	-450,000
Free Cash Flow	-27.05M
FCF Per Share	-1.21

Margins

Gross Margin	100.00%
Operating Margin	-1,721.44%
Pretax Margin	-1,824.86%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

EPA:OSE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.76%
Shareholder Yield	-3.76%
Earnings Yield	-30.52%
FCF Yield	-25.39%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2